Aldeyra Therapeutics, Inc. Common Stock (ALDX) Stock
NASDAQ · ALDX
1.35
Fundamentals
Market cap
$82.04M
Price / Earnings ratio
-3.6x
Price / Sales ratio
N/A
Price / Book ratio
2.2x
Return on assets
-0.4%
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.0%
Debt / Equity ratio
N/A
Latest news
About Aldeyra Therapeutics, Inc. Common Stock
No description available.
SectorHealthcare
IndustryBiotechnology
Employees6
CEODr. Todd C. Brady M.D., Ph.D.
IPO DateApr 11, 2014
HeadquartersLexington, MA
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Dr. Todd C. Brady M.D., Ph.D. | CEO, President & Director | 1972 |
| Mr. Michael Alfieri | Head of Finance and Principal Financial & Accounting Officer | 1965 |
| David Burke | Head of Investor Relations | — |
| Laura Nichols | Operations Manager | — |
| Dr. Adam Lazorchak | Director of Translational Sciences & Non-Clinical Development | — |
Fundamentals
Valuation
Market cap$82.04M
Price-to-sales ratioN/A
Price-to-book value2.16
Price-earnings ratio-3.60
Return on Equity-57.00%
Return on SalesN/A
Return on AssetsN/A
PEG ratio0.00
Earnings Per Share
Earnings Per Share$-0.38
Income Statement
Average volume641,736
EBITDA$-25.22M
1 year high (52w)$5.93
1 year low (52w)$1.07
Dividend
Ex dividend dateN/A
Dividend amount$0.00
Dividend yield0.00%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A



